American Association for Cancer Research Annual Meeting

The latest news from AACR, including researcher interviews and physician perspective.

Meeting News

AACR Annual Meeting likely to be held this summer; ‘virtual’ preview planned for April

March 20, 2020
American Association for Cancer Research expects to reschedule this year’s AACR Annual Meeting for this summer. Association officials decided…
Meeting News

AACR postpones annual meeting due to COVID-19 concerns

March 10, 2020
American Association for Cancer Research’s board of directors has postponed the AACR Annual Meeting due to concerns related to the novel…
Meeting News

Rucaparib maintenance therapy may benefit certain patients with advanced pancreatic cancer

April 8, 2019
ATLANTA — Patients with advanced BRCA- or PALB2-mutated pancreatic cancer sensitive to platinum-based chemotherapy demonstrated sustained…
Meeting News

Gene variant linked to stroke risk in survivors of childhood cancer

April 5, 2019
ATLANTA — A research team at St. Jude Children’s Research Hospital has identified a single nucleotide polymorphism that may increase risk…
Feature

Trial explores T-cell therapy’s role in personalized treatment for lung cancer

April 4, 2019
ATLANTA — In the battle against non-small cell lung cancer, the ability to personalize treatment may be a key to victory, according to Karen
Meeting NewsPerspective

Gilteritinib represents ‘major change’ for treatment of relapsed, refractory acute myeloid leukemia

April 4, 2019
ATLANTA – The FLT3 inhibitor gilteritinib significantly prolonged survival compared with standard salvage chemotherapy in patients with…
Meeting NewsPerspective

Pembrolizumab shows durable benefit as third-line treatment of advanced small cell lung cancer

April 3, 2019
ATLANTA — Pembrolizumab demonstrated antitumor activity and induced durable responses in patients with advanced small cell lung cancer who had…
Meeting News

Tools to better assess tumor heterogeneity will ‘shed new light’ on cancer research, treatment

April 2, 2019
ATLANTA — Emerging technology is providing researchers with the tools to better understand the relationships among cells in the tumor…
Meeting NewsPerspective

Osimertinib plus intermittent selumetinib shows preliminary activity in EGFR-mutated lung cancer

April 2, 2019
ATLANTA — Osimertinib plus intermittent selumetinib demonstrated preliminary antitumor activity and acceptable toxicity in patients with…
Meeting NewsPerspective

Adults at high risk for HIV show ‘alarmingly’ low HPV vaccination rate

April 2, 2019
ATLANTA — Adults at high risk for HIV infection based on injectable drug use or high-risk sexual behavior showed low rates of HPV vaccination…